Logo for Apogee Therapeutics Inc

Apogee Therapeutics Inc Investor Relations Material

Latest events

Logo for Apogee Therapeutics Inc

Status Update

Apogee Therapeutics Inc
Logo for Apogee Therapeutics Inc

Status Update

2 Dec, 2024
Logo for Apogee Therapeutics Inc

Q3 2024

12 Nov, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies

Latest reports from Apogee Therapeutics Inc

Access all reports
Apogee Therapeutics Inc. (APGE) is a biotechnology company engaged in the development of differentiated biologics for the treatment of various inflammatory and immunology (I&I) diseases, including atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and other conditions with high unmet medical needs. The company's approach is focused on creating best-in-class therapies that aim to improve upon the current standard of care for these conditions. The company is headquartered in San Francisco, California, and Waltham, Massachusetts, and its shares are listed on the Nasdaq.